Guest Editor Information Here you will find information about the Guest Editors for recent Special Series issues October 10, 2009 - Cancer and Thrombosis Anna Falanga, MD Ospedali Riuniti di Bergamo, Bergamo, Italy Anna Falanga is chief of the Division of Immunohematology/Transfusion Medicine and the Hemostasis and Thrombosis Center at the Department of Oncology-Hematology of Ospedali Riuniti di Bergamo, Bergamo, Italy. Having received her medical degree and board certification in internal medicine at the University of Naples, she obtained her board certification in hematology at the University of Verona, Italy. She spent 3 years as a postdoctoral fellow at the Mario Negri Institute in Milan, Italy, and an additional 2 years at the University of Colorado School of Medicine, Denver, CO. Research lines in her laboratory include the impact of malignant disease on the host hemostatic system, including the characterization of tumor cell procoagulant activities; the pathogenesis and management of the thrombophilic state associated with malignancy; and clinical trials to test the efficacy and safety of anticoagulant drugs in patients with cancer. She is a member of the panel of experts and a co-chair for the preparation of the guidelines on prophylaxis and treatment of venous thromboembolism for the Italian Society of Medical Oncology, the American Society of Clinical Oncology, and the European Society of Medical Oncology. Alok A. Khorana, MD James P. Wilmot Cancer Center, Rochester, NY Alok A. Khorana, MD, is associate professor of medicine and oncology and vice-chief, Division of Hematology/Oncology, at the James P. Wilmot Cancer Center, University of Rochester, Rochester, NY. His clinical and translational research program focuses on predictive factors in cancer-associated thrombosis. Dr Khorana received his medical degree from Maharaja Sayajirao University’s Medical College in Baroda (Gujarat), India. His postdoctoral training included a residency in internal medicine at the University at Buffalo in New York and a fellowship in hematology/oncology at the University of Rochester. He is a fellow of the American College of Physicians. Dr Khorana is co-chair of the International Society on Thrombosis and Haemostasis Scientific Subcommittee on Hemostasis and Malignancy and serves on the American Society of Clinical Oncology Venous Thromboembolism Guidelines Panel. He is also a member of the US Pharmacopoeia Oncology Expert Committee and the gastrointestinal committees of the Southwest Oncology Group and American College of Surgeons Oncology Group. Gary H. Lyman, MD, MPH, FRCP(Edin) Duke University, Durham, NC Gary H. Lyman, MD, MPH, FRCP(Edin), is professor of medicine and director of health services, effectiveness and outcomes research in oncology at Duke University and Duke Comprehensive Cancer Center, where he is also senior fellow at Duke Center for Clinical Health Policy Research. Before relocating to Duke University in 2007, Dr Lyman held positions as Thomas Ordway Professor of Medicine and cancer center director at Albany Medical College and subsequently associate cancer center director and professor and director of health services and outcomes research at the University of Rochester and Strong Memorial Hospital. Dr Lyman is active with the American Society of Clinical Oncology (ASCO), serving as a member of both the Cancer Education and the Health Services Committees, chairing the Methodology Subcommittee, as well as leading several clinical practice guideline panels, including the recent ASCO Guideline on Prevention and Treatment of Venous Thromboembolism in Patients with Cancer. Dr Lyman is a member of the Oncology Drug Advisory Committee (ODAC) to the US Food and Drug Administration.